Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial

por Martin, Alan, Shah, Dhvani, Ndirangu, Kerigo, Anley, Glenn A., Okorogheye, Gabriel, Schroeder, Melanie, Risebrough, Nancy, Ismaila, Afisi S.
Publicado 2022

Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor–methotrexate combination therapy versus triple therapy in rheumatoid arth...

por Fleischmann, Roy, Tongbram, Vanita, van Vollenhoven, Ronald, Tang, Derek H, Chung, James, Collier, David, Urs, Shilpa, Ndirangu, Kerigo, Wells, George, Pope, Janet
Publicado 2017

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial

por Ismaila, Afisi S, Risebrough, Nancy, Schroeder, Melanie, Shah, Dhvani, Martin, Alan, Goodall, Emma C, Ndirangu, Kerigo, Criner, Gerard, Dransfield, Mark, Halpin, David MG, Han, MeiLan K, Lomas, David A
Publicado 2019